High Tide (HITI) Competitors

$2.21
-0.18 (-7.53%)
(As of 05/17/2024 ET)

HITI vs. DRTS, CGEN, OM, GNFT, ADVM, LFCR, OBIO, TELO, GALT, and GLSI

Should you be buying High Tide stock or one of its competitors? The main competitors of High Tide include Alpha Tau Medical (DRTS), Compugen (CGEN), Outset Medical (OM), Genfit (GNFT), Adverum Biotechnologies (ADVM), Lifecore Biomedical (LFCR), Orchestra BioMed (OBIO), Telomir Pharmaceuticals (TELO), Galectin Therapeutics (GALT), and Greenwich LifeSciences (GLSI). These companies are all part of the "medical" sector.

High Tide vs.

High Tide (NASDAQ:HITI) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment, valuation and community ranking.

High Tide has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than High Tide, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
High Tide$361.57M0.48-$29.14M-$0.33-6.70
Alpha Tau MedicalN/AN/A-$29.16M-$0.42-6.74

High Tide has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500.

High Tide presently has a consensus target price of $4.50, suggesting a potential upside of 103.62%. Alpha Tau Medical has a consensus target price of $12.00, suggesting a potential upside of 324.03%. Given Alpha Tau Medical's higher probable upside, analysts plainly believe Alpha Tau Medical is more favorable than High Tide.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
High Tide
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Alpha Tau Medical
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

Alpha Tau Medical has a net margin of 0.00% compared to High Tide's net margin of -7.46%. High Tide's return on equity of -2.03% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
High Tide-7.46% -2.03% -1.23%
Alpha Tau Medical N/A -31.86%-26.42%

4.5% of High Tide shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 12.4% of High Tide shares are owned by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Alpha Tau Medical had 2 more articles in the media than High Tide. MarketBeat recorded 3 mentions for Alpha Tau Medical and 1 mentions for High Tide. Alpha Tau Medical's average media sentiment score of 0.69 beat High Tide's score of 0.62 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
High Tide
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Alpha Tau Medical received 3 more outperform votes than High Tide when rated by MarketBeat users. Likewise, 60.00% of users gave Alpha Tau Medical an outperform vote while only 39.13% of users gave High Tide an outperform vote.

CompanyUnderperformOutperform
High TideOutperform Votes
9
39.13%
Underperform Votes
14
60.87%
Alpha Tau MedicalOutperform Votes
12
60.00%
Underperform Votes
8
40.00%

Summary

Alpha Tau Medical beats High Tide on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HITI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HITI vs. The Competition

MetricHigh TideRetail stores IndustryMedical SectorNASDAQ Exchange
Market Cap$175.32M$4.27B$5.10B$7.94B
Dividend YieldN/A4.56%37.31%3.91%
P/E Ratio-6.7011.18180.2818.78
Price / Sales0.4814.082,396.36111.67
Price / Cash9.267.4136.5132.08
Price / Book1.672.065.734.68
Net Income-$29.14M$154.47M$105.15M$217.01M
7 Day Performance-2.64%10.18%1.87%2.90%
1 Month PerformanceN/A25.51%4.75%6.58%
1 Year Performance70.00%-30.70%7.68%10.15%

High Tide Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRTS
Alpha Tau Medical
2.8583 of 5 stars
$2.63
-0.8%
$12.00
+355.6%
-15.5%$183.51MN/A-6.27121Analyst Forecast
News Coverage
CGEN
Compugen
1.0686 of 5 stars
$2.09
+3.0%
$4.00
+91.4%
+174.3%$181.04M$33.46M-9.5068Upcoming Earnings
News Coverage
OM
Outset Medical
0.7704 of 5 stars
$3.50
+12.9%
$5.42
+54.8%
-82.0%$181.02M$130.38M-1.04480Gap Up
GNFT
Genfit
1.2127 of 5 stars
$3.69
flat
$11.00
+198.1%
-14.4%$183.94M$28.57M0.00159Analyst Forecast
Short Interest ↓
News Coverage
ADVM
Adverum Biotechnologies
3.7902 of 5 stars
$8.93
-2.6%
$29.00
+224.7%
+1.7%$185.39M$3.60M-0.88121Analyst Forecast
Short Interest ↑
LFCR
Lifecore Biomedical
1.4293 of 5 stars
$6.12
+0.2%
$9.50
+55.2%
+17.9%$185.56M$103.27M-1.83459News Coverage
OBIO
Orchestra BioMed
1.1983 of 5 stars
$5.20
+13.0%
$17.00
+226.9%
-73.4%$186.11M$2.76M-3.4756Analyst Revision
TELO
Telomir Pharmaceuticals
0 of 5 stars
$6.31
-5.4%
N/AN/A$186.69MN/A0.001
GALT
Galectin Therapeutics
0.9364 of 5 stars
$2.84
-7.8%
$11.00
+287.3%
+93.4%$175.80MN/A-3.8428Earnings Report
Upcoming Earnings
Short Interest ↑
GLSI
Greenwich LifeSciences
2.6667 of 5 stars
$13.64
+4.4%
$36.00
+163.9%
+19.1%$175.68MN/A-19.493News Coverage
Positive News
Gap Up

Related Companies and Tools

This page (NASDAQ:HITI) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners